Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Aug;88(8):749-750.
doi: 10.1007/s12098-021-03851-0. Epub 2021 Jun 23.

Utility of Nebulized Magnesium Sulfate Therapy for Persistent Pulmonary Hypertension of Newborn

Adhisivam Bethou  1
Affiliations
Editorial

Utility of Nebulized Magnesium Sulfate Therapy for Persistent Pulmonary Hypertension of Newborn

Adhisivam Bethou. Indian J Pediatr. 2021 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

References

    1. Chawla D. Vasopressin in persistent pulmonary hypertension of newborn. Indian J Pediatr. 2021;88:431–432. doi: 10.1007/s12098-021-03732-6. - DOI - PubMed
    1. Ho JJ, Rasa G. Magnesium sulfate for persistent pulmonary hypertension of the newborn. Cochrane Database Syst Rev. 2007; CD00558. 10.1002/14651858.CD005588. - PMC - PubMed
    1. Abdelkreem E, Mahmoud SM, Aboelez MO, Abd El Aal M. Nebulized magnesium sulfate for treatment of persistent pulmonary hypertension of newborn: a pilot randomized controlled trial. Indian J Pediatr. 2021. 10.1007/s12098-020-03643-y. - PMC - PubMed
    1. Patole SK, Finer NN. Experimental and clinical effects of magnesium infusion in the treatment of neonatal pulmonary hypertension. Magnes Res. 1995;8:373–388. - PubMed
    1. Abdalsalam AA, Mahmoud RA, Mohamed MA, Hadhoud SE. Inhalational versus intravenous magnesium sulfate in management of pulmonary hypertension in neonates. Sohag Med J. 2020;24:1–13.

MeSH terms

LinkOut - more resources